Prospective Surveillance of Enterovirus D68 Improves Epidemiologic Knowledge
Prospective surveillance of enterovirus D68 is contributing to a better understanding of its epidemiology and should be continued.
Lung Infections
Inhaled Molgramostim Granted Fast Track Status for Autoimmune Pulmonary Alveolar Proteinosis
The FDA has granted Fast Track designation to Molgradex (molgramostim; Savara) for the treatment of autoimmune pulmonary alveolar proteinosis.
Internet-Based Communication Training May Reduce Antibiotic Prescribing in RTIs
An internet-based training program designed to enhance communication skills in C-reactive protein point of care testing may be helpful in reducing long-term antibiotic prescribing in respiratory tract infections.
Telemedicine May Lead to More Antibiotics in Pediatric Respiratory Infection
More antibiotics are prescribed with less guideline-concordant antibiotic management in telemedicine vs other settings.
Nasopharyngeal Microbiota Could Help Diagnose Pediatric Lower RTIs
Research suggests nasopharyngeal microbiota can be valid proxy for lower respiratory tract microbiota.
DG/health NATURALS Cough Syrup + Mucus for Infants Recalled
One lot of DG/health NATURALS baby Cough Syrup + Mucus is being recalled due to possible contamination with potentially harmful bacteria.
Bronchiolitis Hospitalization in Infancy Predicts More Admissions
More than 1 in 5 infants with a bronchiolitis hospital admission will have a subsequent respiratory-related hospital admission by age 5 years.
Does Elderberry Supplementation Reduce Upper Respiratory Symptoms?
Elderberry supplementation may reduce the duration and severity of upper respiratory symptoms.
Legionella Outbreaks on the Rise: Could Climate Change Be Responsible?
Lack of plumbing maintenance; aging infrastructure; warm, humid climates; and exposure to the immunocompromised may contribute to an increase in Legionnaires disease.
SynGEM Intranasal Vaccine for RSV Generates Durable Immune Response
SynGEM, an intranasal subunit vaccine that introduces the respiratory syncytial virus (RSV), has demonstrated efficacy in actuating lasting immune responses in humans.
Next post in Lung Infection
